Eli Lilly could have the 'biggest drug in history' in its pipeline, says Jim Cramer
'Mad Money' host Jim Cramer joins 'Squawk Box' ahead of the open on Thursday to react to earnings reports from Eli Lilly and Paramount Global.
Видео Eli Lilly could have the 'biggest drug in history' in its pipeline, says Jim Cramer канала CNBC Television
Видео Eli Lilly could have the 'biggest drug in history' in its pipeline, says Jim Cramer канала CNBC Television
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
3-Stock Lunch: Nike, Fedex, & Lennar
There's still a lot of capital that wants to come into this market, says Citi's Kristen Bitterly
Nike's challenges are quite similar to what we're seeing at Starbucks, says Peter Atwater
Breaking down shares of Hilton, Expedia and Match Group
Evercore's Roger Altman on the economy: A nearly perfect overall environment
Three-Stock Lunch: S&P Homebuilders Index, Nvidia & JPMorgan
Making friends with 'Pie': CEO Andy Dunn on the new social app
Trade Tracker: Kevin Simpson buys more Freeport-McMoran
Vernon: Both FedEx and UPS are well-positioned to leverage pricing power despite current pressures
New Nike CEO a 'good man' to rejuvenate its culture, says Stifel's Jim Duffy
Squawk Pod: A new CEO at Nike & new ‘Grit & Wit’ on Shark Tank - 09/20/24 | Audio Only
The competitiveness of AI will be both technically and energy-driven, says Peter Huntsman
Mitrione: The market is really happy with lower rates. Tech benefits a lot from them.
Alaska Airlines CEO on Hawaiian merger: It's pro-consumer and pro-competition
The Fed has done its job using its narrative to loosen financial markets: RXR Realty's Scott Rechler
Some retail stocks at 'inflection points' & can be defensive play, says William Blair's Dylan Carden
Opening Bell, December 15, 2022
Expect Apple to benefit from its Apple Intelligence software, says Bernstein's Toni Sacconaghi
Supreme Court to hear Coinbase user arbitration dispute
Calls of the Day: Elanco Animal Health CEO, Casey's General Store, GE Vernova, Spotify
'Good news actually means good news' in this market, says Guggenheim's Eric Mandl